Indian Pharma Group Petitions NPPA to Establish Prospective Batch Pricing

May 23, 2023

When India’s National Pharmaceutical Pricing Authority (NPPA) sets ceiling prices for drugs, pharma companies can be fined if even one pharmacist charges higher. As a result, the Indian Drug Manufacturer’s Association (IDMA), should put in place prospective price batching that would apply the new price to the next batch of drugs being released.

According to Shardul Nautiyal, “To overcome this genuine issue, IDMA has suggested that para 2(e) of Drug Prices Control Order (DPCO), 2013 be modified to delete the word ‘Retailer’ from the definition of the ‘Dealer’ as the pharmaceutical companies have no control over prices charged by the retailers. As per the current DPCO 2013, “Dealer” means a person carrying on the business of purchase or sale of drugs, whether as a wholesaler or retailer and includes his agent.”

To read more, click here.

(Source: Pharma Biz, May 22nd, 2023)

Share This Story!